Correlation Between Cadrenal Therapeutics, and Chimerix
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Chimerix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Chimerix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Chimerix, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Chimerix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Chimerix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Chimerix.
Diversification Opportunities for Cadrenal Therapeutics, and Chimerix
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cadrenal and Chimerix is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Chimerix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chimerix and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Chimerix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chimerix has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Chimerix go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and Chimerix
Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to under-perform the Chimerix. In addition to that, Cadrenal Therapeutics, is 1.65 times more volatile than Chimerix. It trades about -0.05 of its total potential returns per unit of risk. Chimerix is currently generating about 0.06 per unit of volatility. If you would invest 87.00 in Chimerix on August 25, 2024 and sell it today you would earn a total of 3.00 from holding Chimerix or generate 3.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. Chimerix
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| Chimerix |
Cadrenal Therapeutics, and Chimerix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and Chimerix
The main advantage of trading using opposite Cadrenal Therapeutics, and Chimerix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Chimerix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chimerix will offset losses from the drop in Chimerix's long position.The idea behind Cadrenal Therapeutics, Common and Chimerix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Chimerix vs. Lyra Therapeutics | Chimerix vs. Hookipa Pharma | Chimerix vs. SAB Biotherapeutics | Chimerix vs. Cadrenal Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |